Please call your physician’s office before coming in for your appointment if you have symptoms of a cough, fever, or difficulty breathing; traveled to Europe or China or other areas impacted by the coronavirus (COVID-19) within the past 14 days; been in close contact with someone who has traveled outside the U.S. to one of the impacted countries; or may have been exposed to the coronavirus. Effective Monday May 18th all VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Our new office hours are: Monday through Friday 8:30 a.m. to 4:00 p.m, if you have an appointment scheduled for after hours, our office will be contacting you directly to reschedule. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Clinical Trials at Virginia Cancer Specialists

Virginia Cancer Specialists » Protected: Chemotherapy Class » Clinical Trials at Virginia Cancer Specialists

Clinical Research Locations

Alexandria Office

Arlington Infusion Suite

Fairfax Office

Gainesville Office

Loudoun Office

Because Virginia Cancer Specialists is committed to providing the best available care to all of its patients, research is and will continue to be the cornerstone of the organization. Such research offers patients access to new investigational drugs not always available to the general public.

VCS participates in many clinical trials, which show us what works (and what doesn’t) in medicine. They are the best way for doctors to learn what is safe and effective in treating diseases such as cancer. Such research offers VCS access to new investigational drugs, reduces treatment-related side effects and introduces new methods of care.

As part of its cutting-edge program, VCS has available to its patients, more than any other program in the Metropolitan D.C. area.  VCS has open studies across almost all tumor types, including lung, head and neck, breast, melanoma, lymphoma, bladder, uterine, ovarian, and brain.  By restoring the immune system’s recognition of cancer cells, this class of drugs hopes to revolutionize cancer care.

The VCS Research Institute prides itself on providing a quality program right in Northern Virginia.  Providing top-notch care and the latest, cutting-edge trials allows the program to study new and potentially life-saving treatments.  The VCS Research Institute was recognized by INC Research, LLC, for its outstanding research program and speedy and smooth start-up timelines in 2014.